NO‐ and haem‐independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle
Johannes‐Peter Stasch(Bayer (Germany)), Frank Wunder(Drug Discovery Laboratory (Norway))
Cited by 311
Related Papers
The Concise Guide to PHARMACOLOGY 2023/24: Enzymes
|British Journal of Pharmacology|2023|442
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes
|British Journal of Pharmacology|2021|384
The Concise Guide to PHARMACOLOGY 2023/24: Catalytic receptors
|British Journal of Pharmacology|2023|156
Development of Potent and Metabolically Stable APJ Ligands with High Therapeutic Potential
|ChemMedChem|2016|34
Phenotypes of sGC mutant mice in basic conditions, disease and shock
|BMC Pharmacology|2009|3